1. AB0905 Long-term (5-YEAR) efficacy and safety of apremilast monotherapy in dmard-naÏve subjects with active psoriatic arthritis. (12th June 2018) Authors: Wells, A.F.; Edwards, C.J.; Kivitz, A.J.; Bird, P.; Guerette, B.; Delev, N.; Paris, M.; Teng, L.; Aelion, J.A. Journal: Annals of the rheumatic diseases Issue: Volume 77(2018)Supplement 2 Page Start: 1576 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. AB0954 A randomised, double-blind trial comparing the efficacy, safety and immunogenicity of msb11022, a proposed biosimilar of adalimumab, versus adalimumab originator in patients with moderate-to-severe plaque psoriasis. (12th June 2018) Authors: Hercogová, J.; Papp, K.A.; Edwards, C.J.; Chyrok, V.; Halady, T.; Ullmann, M.; Vlachos, P. Journal: Annals of the rheumatic diseases Issue: Volume 77(2018)Supplement 2 Page Start: 1602 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. AB1115-HPR Dose Reduction of Biological Therapies in Rheumatoid Arthritis - The Patient's Perspective. (15th July 2016) Authors: Wallis, D.; Holroyd, C.; Sonpal, K.; Zarroug, J.; Adams, J.; Edwards, C.J. Journal: Annals of the rheumatic diseases Issue: Volume 75(2016)Supplement 2 Page Start: 1313 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
4. AB1471-HPR The reliability and validity of a novel MRI-based tool for the evaluation of forefoot bursae in patients with rheumatoid arthritis: The "FFB-score". (23rd January 2014) Authors: Hooper, L.; King, L.; Thomas, M.; Roemer, F.; Culliford, D.; Bowen, C.; Arden, N.K.; Edwards, C.J. Journal: Annals of the rheumatic diseases Issue: Volume 71(2012)Supplement 3 Page Start: 759 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
5. AURIEL‐PsO: a randomized, double‐blind phase III equivalence trial to demonstrate the clinical similarity of the proposed biosimilar MSB11022 to reference adalimumab in patients with moderate‐to‐severe chronic plaque‐type psoriasis. (26th September 2019) Authors: Hercogová, J.; Papp, K.A.; Chyrok, V.; Ullmann, M.; Vlachos, P.; Edwards, C.J. Journal: British journal of dermatology Issue: Volume 182:Number 2(2020) Page Start: 316 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
6. AURIEL‐PsO: a randomized, double‐blind phase III equivalence trial to demonstrate the clinical similarity of the proposed biosimilar MSB11022 to reference adalimumab in patients with moderate‐to‐severe chronic plaque‐type psoriasis. (1st February 2020) Authors: Hercogová, J.; Papp, K.A.; Chyrok, V.; Ullmann, M.; Vlachos, P.; Edwards, C.J. Journal: British journal of dermatology Issue: Volume 182:Number 2(2020) Page Start: 316 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
7. FRI0055 Safety of etanercept in elderly patients with rheumatoid arthritis: a pooled analysis. (12th June 2018) Authors: Edwards, C.J.; Roshak, K.; Bukowski, J.; Pedersen, R.; Thakur, M.; Marshall, L.; Jones, H. Journal: Annals of the rheumatic diseases Issue: Volume 77(2018)Supplement 2 Page Start: 574 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
8. FRI0154 Are There Negative Effects on Disease Activity and Function Associated with Failed Anti-TNF Dose Reduction Strategies for RA Patients?. (15th July 2016) Authors: Serhal, L.; Holroyd, C.; Zarroug, J.; Armstrong, R.; Davidson, B.; Harvey, N.; Dennison, E.; Cooper, C.; Edwards, C.J. Journal: Annals of the rheumatic diseases Issue: Volume 75(2016)Supplement 2 Page Start: 484 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
9. FRI0195 ERAP1 Allotypes and Disease Severity in Ankylosing Spondylitis. (9th June 2015) Authors: Fong, W.; Reeves, E.; Tim, W.; Elliot, T.; James, E.; Edwards, C.J. Journal: Annals of the rheumatic diseases Issue: Volume 74(2015)Supplement 2 Page Start: 495 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
10. FRI0211 Tapering MTX versus Steady-State MTX in Combination with Tocilizumab for Treatment of Rheumatoid Arthritis (ACT-TAPER): A Randomised, Double-Blind, Controlled Phase 4 Trial. (15th July 2016) Authors: Edwards, C.J.; Kiely, P.; Ostor, A.; Naisbett-Groet, B. Journal: Annals of the rheumatic diseases Issue: Volume 75(2016)Supplement 2 Page Start: 508 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗